⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28932 | 0.72 | — | — | |
| SCHEMBL5841665 | 0.72 | — | — | |
| SCHEMBL3401 | 0.72 | — | — | |
| SCHEMBL1766147 | 0.67 | — | — | |
| SCHEMBL757022 | 0.67 | — | — | |
| Ammonia Solution, Strong SCHEMBL28635407 | 0.67 | — | — | |
| SCHEMBL4237162 | 0.67 | — | — | |
| SCHEMBL9791634 | 0.64 | — | — | |
| SCHEMBL25241620 | 0.62 | — | — | |
| SCHEMBL175942 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1973550-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN ENHANCED PHARMACOKINETIC PROFILE | Tika Läkemedel AB (SE) | 2008-10-01 | — | — | EP | disclosed |
| EP-1971347-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS | Tika Läkemedel AB (SE) | 2008-09-24 | — | — | EP | disclosed |
| EP-1971349-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN INCREASED LUNG DEPOSITION | Tika Läkemedel AB (SE) | 2008-09-24 | — | — | EP | disclosed |
| EP-1971345-A2 | METHOD AND SYSTEM FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN ENHANCED PHARMACOKINETIC PROFILE | Tika Läkemedel AB (SE) | 2008-09-24 | — | — | EP | disclosed |
| EP-1971348-A2 | SYSTEMS AND METHODS FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN INCREASED LUNG DEPOSITION | Tika Läkemedel AB (SE) | 2008-09-24 | — | — | EP | disclosed |
| EP-1971346-A2 | SYSTEMS AND METHODS FOR THE DELIVERY OF CORTICOSTEROIDS | Tika Läkemedel AB (SE) | 2008-09-24 | — | — | EP | disclosed |
| WO-2007075798-A9 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN INCREASED LUNG DEPOSITION | VERUS PHARMACEUTICALS INC (US) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007075801-A2 | METHOD AND SYSTEM FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN ENHANCED PHARMACOKINETIC PROFILE | TIKA LÄKEMEDEL AB (SE) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007075800-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS | TIKA LÄKEMEDEL AB (SE) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007075859-A2 | SYSTEMS AND METHODS FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN INCREASED LUNG DEPOSITION | TIKA LÄKEMEDEL AB (SE) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007075799-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN ENHANCED PHARMACOKINETIC PROFILE | TIKA LÄKEMEDEL AB (SE) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007075798-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN INCREASED LUNG DEPOSITION | TIKA LAKEMEDEL AB (SE) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007075963-A2 | SYSTEMS AND METHODS FOR THE DELIVERY OF CORTICOSTEROIDS | TIKA LÄKEMEDEL AB (SE) | 2007-07-05 | — | — | WO | disclosed |
| EP-1272198-A1 | USE OF ORGANOPHOSPHOROUS COMPOUNDS FOR PRODUCING A MEDICAMENT FOR TREATING INFECTIONS | Jomaa Pharmaka GmbH (DE) | 2003-01-08 | — | — | EP | disclosed |
| WO-2001070237-A1 | USE OF ORGANOPHOSPHOROUS COMPOUNDS FOR PRODUCING A MEDICAMENT FOR TREATING INFECTIONS | JOMAA PHARMAKA GMBH (DE) | 2001-09-27 | — | — | WO | disclosed |